Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1, Double-Blind, Placebo-Controlled Multiple Dose Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine

NCT00265265 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.

NCT NCT00265265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00265265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1, Double-Blind, Placebo-Controlled Multiple Dose Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine
Lead sponsor
National Institute on Drug Abuse (NIDA)
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2005
Completion date
Not reported
Enrollment
16
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine-related disorders